Novartis cuts CCO title as international chief Marie-France

Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.

Executives Fierce Pharma

Novartis details plans to cut 8,000 jobs worldwide

2021 Q1 Results Presentation & Transcript

Michael Meegan on LinkedIn: Novartis cuts top commercial title, replaces departing exec Marie-France…

News - GalChimia

Novartis names new board member after international boss steps

Novartis to cut up to 8,000 jobs globally

Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group - eClinicalMedicine

RCSI Alumni Magazine 2021 by RCSI - Issuu

Digital Media News from CNW : Masthead Online - Headline News

Novartis appoints Patrick Horber, M.D., President, International as Marie- France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, steps down from the Executive Committee of Novartis

Frontiers Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches

NOVARTIS AG - 8.1 For a list of all of our principal Group subsidiaries and associated companies, see “Item 18. Financial Statements—Note 32. Principal Group subsidiaries and associated companies.”* - 20-F - February 02, 2022